Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Regulation of RAF family kinases: new insights from recent structural and biochemical studies
  2. Spencer-Smith, Russell; Morrison,Deborah
  3. Biochemical Society Transactions. 2024, June 26; 52(3): 1061-1069.
  1. 2.   Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
  2. Pahwa, Roma; Dubhashi, Janhavi; Singh, Anand; Jailwala, Parthav; Lobanov,Alexei; Thomas, Craig J; Ceribelli, Michele; Wilson, Kelli; Ricketts, Christopher J; Vocke, Cathy D; Wells, Catherine; Bottaro, Donald P; Linehan, W Marston; Neckers, Len; Srinivasan, Ramaprasad
  3. Journal of Experimental & Clinical Cancer Research : CR. 2022, Jun 27; 41(1): 208.
  1. 3.   ß-hCG induced mutant BRCA1 ignites drug resistance in susceptible breast tissue
  2. Sengodan,Satheesh; Hemalatha, Sreelatha K; Nadhan, Revathy; Somanathan, Thara; Mathew, Arun Peter; Chil, Arkadiusz; Kopczynski, Janusz; Nair, Rakesh Sathish; Kumar, Jerald Mahesh; Srinivas, Priya
  3. Carcinogenesis. 2019, Nov; 40(11): 1415-1426.
  1. 4.   First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile
  2. Speranza, Giovanna; Anderson, Larry; Chen, Alice P; Do, Khanh; Eugeni, Michelle; Weil, Marcie; Rubinstein, Larry; Majerova, Eva; Collins, Jerry; Horneffer, Yvonne; Juwara, Lamin; Zlott, Jennifer; Bishop, Rachel; Conley, Barbara A; Streicher, Howard; Tomaszewski, Joseph; Doroshow, James H; Kummar, Shivaani
  3. Investigational New Drugs. 2018, Apr; 36(2): 230-239.
  1. 5.   Methoxychalcone inhibitors of androgen receptor translocation and function
  2. Kim, Y. S.; Kumar, V.; Lee, S.; Iwai, A.; Neckers, L.; Malhotra, S. V.; Trepel, J. B.
  3. Bioorganic & Medicinal Chemistry Letters. 2012, Mar; 22(5): 2105-2109.
  1. 6.   Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry
  2. Jain, L.; Gardner, E. R.; Venitz, J.; Giaccone, G.; Houk, B. E.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2010, Nov; 878(30): 3187-3192.
  1. 7.   Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
  2. Kummar, S.; Gutierrez, M. E.; Gardner, E. R.; Chen, X. H.; Figg, W. D.; Zajac-Kaye, M.; Chen, M.; Steinberg, S. M.; Muir, C. A.; Yancey, M. A.; Horneffer, Y. R.; Juwara, L.; Melillo, G.; Ivy, S. P.; Merino, M.; Neckers, L.; Steeg, P. S.; Conley, B. A.; Giaccone, G.; Doroshow, J. H.; Murgo, A. J.
  3. European Journal of Cancer. 2010, Jan; 46(2): 340-347.
  1. 8.   New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
  2. De Martino, G.; Edler, M. C.; La Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 947-954.
  1. 9.   In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
  2. Hollingshead, M.; Alley, M.; Burger, A. M.; Borgel, S.; Pacula-Cox, C.; Fiebig, H. H.; Sausville, E. A.
  3. Cancer Chemotherapy and Pharmacology. 2005, AUG; 56(2): 115-125.
  1. 10.   Enhanced tumor cell radiosensitivity and abrogation of G(2) and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
  2. Bull, E. E. A.; Dote, H.; Brady, K. J.; Burgan, W. E.; Carter, D. J.; Cerra, M. A.; Oswald, K. A.; Hollingshead, M. G.; Camphausen, K.; Tofilon, P. J.
  3. Clinical Cancer Research. 2004, DEC 1; 10(23): 8077-8084.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel